Abstract:Oxidative stress is proposed as a regulatory element in ageing and various neurological disorders. The excess of oxidants causes a reduction of antioxidants, which in turn produce an oxidation–reduction imbalance in organisms. Paucity of the antioxidant system generates oxidative-stress, characterized by elevated levels of reactive species (oxygen, hydroxyl free radical, and so on). Mitochondria play a key role in ATP supply to cells via oxidative phosphorylation, as well as synthesis of essential biological molecules. Various redox reactions catalyzed by enzymes take place in the oxidative phosphorylation process. An inefficient oxidative phosphorylation may generate reactive oxygen species (ROS), leading to mitochondrial dysfunction. Mitochondrial redox metabolism, phospholipid metabolism, and proteolytic pathways are found to be the major and potential source of free radicals. A lower concentration of ROS is essential for normal cellular signaling, whereas the higher concentration and long-time exposure of ROS cause damage to cellular macromolecules such as DNA, lipids and proteins, ultimately resulting in necrosis and apoptotic cell death. Normal and proper functioning of the central nervous system (CNS) is entirely dependent on the chemical integrity of brain. It is well established that the brain consumes a large amount of oxygen and is highly rich in lipid content, becoming prone to oxidative stress. A high consumption of oxygen leads to excessive production of ROS. Apart from this, the neuronal membranes are found to be rich in polyunsaturated fatty acids, which are highly susceptible to ROS. Various neurodegenerative diseases such as Parkinson’s disease (PD), Alzheimer’s disease (AD), Huntington’s disease (HD), and amyotrophic lateral sclerosis (ALS), among others, can be the result of biochemical alteration (due to oxidative stress) in bimolecular components. There is a need to understand the processes and role of oxidative stress in neurodegenerative diseases. This review is an effort towards improving our understanding of the pivotal role played by OS in neurodegenerative disorders.

Oxidative stress in the brain–lung crosstalk: cellular and molecular perspectives

Circular RNAs: Novel Players in the Oxidative Stress-Mediated Pathologies, Biomarkers, and Therapeutic Targets

Landscape analysis and overview of the literature on oxidative stress and pulmonary diseases

Oxidative Stress in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications

Oxidative Stress-Mediated Blood-Brain Barrier (BBB) Disruption in Neurological Diseases

Oxidative stress, the blood–brain barrier and neurodegenerative diseases: The critical beneficial role of dietary antioxidants

Brain Oxidative Stress Contributing to Pathogenesis of Cardiovascular Diseases

Current perspectives on the clinical implications of oxidative RNA damage in aging research: challenges and opportunities

Oxidative Stress: A Key Modulator in Neurodegenerative Diseases

Oxidative Stress at the Crossroads of Aging, Stroke and Depression

The relevant targets of anti-oxidative stress: a review

The pathophysiological role of mitochondrial oxidative stress in lung diseases

Oxidative stress: fundamentals and advances in quantification techniques

Oxidative Stress in COPD: Sources, Markers, and Potential Mechanisms

Anti-oxidative stress treatment and current clinical trials

Safeguarding the brain from oxidative damage

Potential targets and treatments affect oxidative stress in gliomas: An overview of molecular mechanisms

Ozone: complicated effects in central nervous system diseases

Crosstalk between ROS-inflammatory gene expression axis in the progression of lung disorders

CVD and Oxidative Stress

Long Noncoding RNAs in the Regulation of Oxidative Stress